Cargando…
METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma
BACKGROUND: Osteosarcoma (OS) is the most common primary malignant bone tumor in adolescents. The molecular mechanism behind OS progression and metastasis remains poorly understood, which limits the effectiveness of current therapies. RNA N(6)-methyladenosine (m(6)A) modification plays a critical ro...
Autores principales: | Li, Hong-Bo, Huang, Gang, Tu, Jian, Lv, Dong-Ming, Jin, Qing-Lin, Chen, Jun-Kai, Zou, Yu-Tong, Lee, Dung-Fang, Shen, Jing-Nan, Xie, Xian-Biao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272358/ https://www.ncbi.nlm.nih.gov/pubmed/35810559 http://dx.doi.org/10.1016/j.ebiom.2022.104142 |
Ejemplares similares
-
EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis
por: Lang, Fengchao, et al.
Publicado: (2019) -
METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes
por: Moroz‐Omori, Elena V., et al.
Publicado: (2021) -
Interplays of different types of epitranscriptomic mRNA modifications
por: Rengaraj, Praveenkumar, et al.
Publicado: (2021) -
Targeting METTL14 and RNA methylation to treat osteosarcoma
por: Ren, Lili, et al.
Publicado: (2022) -
Alternative splicing of METTL3 explains apparently METTL3-independent m(6)A modifications in mRNA
por: Poh, Hui Xian, et al.
Publicado: (2022)